Profile
Full Name
Cartesian Therapeutics, Inc.Ticker Symbol
RNACExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 22, 2016Indexes
Not includedEmployees
66Key Details
Price
$10.36(-8.80%)
Market cap
$268.40M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$38.91M(+49.64% YoY)
Annual EPS
-$4.49(+90.98% YoY)
PE ratio
-
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Cartesian Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 14, 25 HC Wainwright & Co.
BuyMar 13, 25 Needham
BuyJan 28, 25 HC Wainwright & Co.
BuyJan 27, 25 Needham
BuyJan 13, 25 Needham
BuyDec 19, 24 BTIG
BuyDec 4, 24 HC Wainwright & Co.
BuyDec 3, 24 Needham
BuyNov 25, 24 Needham
BuyNov 8, 24 Needham
BuyInstitutional Ownership
- What is the ticker symbol for Cartesian Therapeutics?
- Does Cartesian Therapeutics pay dividends?
- What sector is Cartesian Therapeutics in?
- What industry is Cartesian Therapeutics in?
- What country is Cartesian Therapeutics based in?
- When did Cartesian Therapeutics go public?
- Is Cartesian Therapeutics in the S&P 500?
- Is Cartesian Therapeutics in the NASDAQ 100?
- Is Cartesian Therapeutics in the Dow Jones?
- When was Cartesian Therapeutics's last earnings report?
- When does Cartesian Therapeutics report earnings?
- Should I buy Cartesian Therapeutics stock now?
What is the ticker symbol for Cartesian Therapeutics?
The ticker symbol for Cartesian Therapeutics is NASDAQ:RNAC
Does Cartesian Therapeutics pay dividends?
No, Cartesian Therapeutics does not pay dividends
What sector is Cartesian Therapeutics in?
Cartesian Therapeutics is in the Healthcare sector
What industry is Cartesian Therapeutics in?
Cartesian Therapeutics is in the Biotechnology industry
What country is Cartesian Therapeutics based in?
Cartesian Therapeutics is headquartered in United States
When did Cartesian Therapeutics go public?
Cartesian Therapeutics's initial public offering (IPO) was on June 22, 2016
Is Cartesian Therapeutics in the S&P 500?
No, Cartesian Therapeutics is not included in the S&P 500 index
Is Cartesian Therapeutics in the NASDAQ 100?
No, Cartesian Therapeutics is not included in the NASDAQ 100 index
Is Cartesian Therapeutics in the Dow Jones?
No, Cartesian Therapeutics is not included in the Dow Jones index
When was Cartesian Therapeutics's last earnings report?
Cartesian Therapeutics's most recent earnings report was on Mar 13, 2025
When does Cartesian Therapeutics report earnings?
The next expected earnings date for Cartesian Therapeutics is May 8, 2025
Should I buy Cartesian Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions